BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260319T080000
DTEND;TZID=Europe/Madrid:20260321T170000
DTSTAMP:20260406T064327
CREATED:20250719T103826Z
LAST-MODIFIED:20250801T203138Z
UID:10000223-1773907200-1774112400@oncodaily.com
SUMMARY:The ICHNO 2026
DESCRIPTION:The ICHNO 2026\, the 10th International Congress on Innovative Approaches in Head and Neck Oncology\, will be held from 19–21 March 2026 in Seville\, Spain\, under the theme: “Driven by Biology\, Centred on the Person.”  \nThis unique event—jointly organized by ESTRO\, EHNS\, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology\, grounded in biology and focused on the individual. \nWith global thought leaders\, impactful research\, and opportunities for meaningful dialogue\, ICHNO 2026 will be a vital platform for education\, exchange\, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO)\, Giovanni Succo (EHNS)\, and Yungan Tao (ESMO). \nMore posts featuring European Society for Radiotherapy and Oncology on OncoDaily.
URL:https://oncodaily.com/event/the-ichno-2026-332267
LOCATION:Fibes – Conference and Exhibition\, Ave. Alcalde Luis Uruñuela\, 1\, Seville\, 41020\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/IMG_7601.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260320T090000
DTEND;TZID=America/Halifax:20260320T100000
DTSTAMP:20260406T064327
CREATED:20260312T121023Z
LAST-MODIFIED:20260312T121023Z
UID:10000690-1773997200-1774000800@oncodaily.com
SUMMARY:Leukemia Maintenance Therapy: From Empiric Knowledge to New Paradigms - Resonance
DESCRIPTION:The ALRCaN (Acute Leukemia Research and Care Network) webinar\, titled “Maintenance therapy of leukemia – A journey from empiric knowledge to basic science and a novel paradigm\,” is scheduled for Friday\, March 20\, 2026\, from 05:00 to 06:00 PM (Armenia Standard Time). \nPresented by Kjeld Schmiegelow\, this session focuses on the evolution of maintenance therapy\, tracing its transition from empirical observations to deep basic science and the emergence of new therapeutic paradigms. This weekly collegial gathering\, hosted by Resonance\, allows experts to share best practices and clinical insights regarding leukemia and supportive care topics to optimize long-term patient outcomes.
URL:https://oncodaily.com/event/leukemia-467858
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Kjeld-Schmiegelow.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20260320T100000
DTEND;TZID=Australia/Melbourne:20260320T163000
DTSTAMP:20260406T064327
CREATED:20260222T124648Z
LAST-MODIFIED:20260222T124648Z
UID:10000664-1774000800-1774024200@oncodaily.com
SUMMARY:Thoracic Oncology Group of Australasia (TOGA) SCLC Masterclass 2026
DESCRIPTION:The Thoracic Oncology Group of Australasia (TOGA) will host its Small Cell Lung Cancer (SCLC) Masterclass on Friday\, March 20\, 2026\, at the Novotel Melbourne on Collins.  \nThis intensive\, face-to-face workshop is designed for healthcare professionals to navigate a pivotal turning point in SCLC management\, as novel therapies begin to challenge long-standing treatment paradigms. Chaired by A/Prof Surein Arulananda and Dr. Rebecca Tay\, the program features international insights from Dr. Maurice Perol (France) on molecular subtypes and new directions\, alongside Australian experts discussing limited-stage and extensive-stage standards of care. Through a combination of case studies and panel debates\, participants will explore emerging data on checkpoint inhibitors\, lurbinectedin\, and tarlatamab\, while addressing practical clinical challenges such as smoking cessation and the management of immune-related toxicities. \nRegister now.
URL:https://oncodaily.com/event/sclc-459535
LOCATION:Novotel Melbourne on Collins\, 270 Collins Street\, Melbourne\, Victoria\, 3000\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/Annotation-2026-02-22-164655-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260321
DTEND;VALUE=DATE:20260323
DTSTAMP:20260406T064327
CREATED:20260112T212322Z
LAST-MODIFIED:20260112T212338Z
UID:10000567-1774051200-1774223999@oncodaily.com
SUMMARY:2026 Single-Cell Cancer Biology Gordon Research Seminar (GRS)
DESCRIPTION:The 2026 Single-Cell Cancer Biology Gordon Research Seminar (GRS) is a specialized forum for PhD students and postdoctoral researchers to share unpublished findings in the field of cancer evolution and plasticity. \nScheduled for March 21–22\, 2026\, in Ventura\, California\, the seminar precedes the larger Gordon Research Conference (GRC) and focuses on integrating single-cell and spatial technologies to decode tumor heterogeneity and clonal dynamics. The program includes a keynote by Dr. Benjamin Izar and a mentorship panel featuring experts from leading oncology institutions. \nApplication.
URL:https://oncodaily.com/event/single-cell-cancer-biology-440376
LOCATION:Four Points Sheraton / Holiday Inn Express\, 1050 Schooner Drive\, Ventura\, CA\, 93001\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Laura-Quevedo.webp
ORGANIZER;CN="Gordon Research Conference":MAILTO:grc@grc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260322
DTEND;VALUE=DATE:20260328
DTSTAMP:20260406T064327
CREATED:20260113T233812Z
LAST-MODIFIED:20260113T233824Z
UID:10000568-1774137600-1774655999@oncodaily.com
SUMMARY:2026 Single-Cell Cancer Biology Gordon Research Conference (GRC)
DESCRIPTION:The 2026 Single-Cell Cancer Biology Gordon Research Conference (GRC) is a premier scientific forum titled “Deciphering the Multimodal and Spatial Drivers of Cancer.” \nScheduled for March 22–27\, 2026\, in Ventura\, California\, this conference brings together global leaders to discuss how single-cell omics and spatial technologies are transforming our understanding of cancer initiation\, progression\, and resistance. The technical program emphasizes the integration of multi-modal data to map the complex interactions within the tumor microenvironment and the clonal dynamics that drive therapeutic failure. \nApplication.
URL:https://oncodaily.com/event/single-cell-cancer-biology-440712
LOCATION:Four Points Sheraton / Holiday Inn Express\, 1050 Schooner Drive\, Ventura\, CA\, 93001\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/GRC.webp
ORGANIZER;CN="Gordon Research Conference":MAILTO:grc@grc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260328
DTSTAMP:20260406T064327
CREATED:20251111T213352Z
LAST-MODIFIED:20251111T213417Z
UID:10000341-1774396800-1774655999@oncodaily.com
SUMMARY:ANZGOG 2026 Annual Scientific Meeting
DESCRIPTION:The ANZGOG 2026 Annual Scientific Meeting is a flagship event of the Australian New Zealand Gynaecological Oncology Group (ANZGOG). The 2026 ASM\, themed “On the Edge: Translating Innovation into Action\,” is scheduled for March 25–27\, 2026\, on the Gold Coast\, Queensland. \nIt serves as a dynamic forum for national and international experts – including gynaecological medicine\, radiation\, and surgical oncologists\, researchers\, nurses\, and industry partners – to engage in bold thinking and action-oriented discussion focused on the future of gynaecological cancer research\, particularly around emerging technologies like artificial intelligence\, the urgent need for pragmatic trials\, and transforming insights from molecular studies and the lived experience of survivors into clinical impact.
URL:https://oncodaily.com/event/anzgog-407506
LOCATION:Gold Coast Convention and Exhibition Centre\, 2684 - 2690 Gold Coast Highway\, Broadbeach\, Queensland\, 4218\, Australia
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/ANZOG.jpg
ORGANIZER;CN="Australian New Zealand Gynaecological Oncology Group":MAILTO:contact@anzgog.org.au
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260326
DTSTAMP:20260406T064327
CREATED:20251228T200222Z
LAST-MODIFIED:20251228T200236Z
UID:10000539-1774396800-1774483199@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Endometrial Cancer 2026 is a specialized virtual scientific meeting scheduled for March 25\, 2026\, focused on the practical application of clinical practice guidelines in the management of endometrial cancer. \nChaired by Ana Oaknin\, the webinar features a multidisciplinary panel of experts who discuss the diagnosis\, staging\, and therapeutic sequencing for endometrial malignancies through the lens of a real-world clinical case. The session provides oncology professionals with 1 ESMO-MORA category 1 point and serves as a forum for translating the latest ESMO Clinical Practice Guidelines into individualized patient care. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-435260
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260328
DTSTAMP:20260406T064327
CREATED:20251204T144747Z
LAST-MODIFIED:20251204T144808Z
UID:10000447-1774396800-1774655999@oncodaily.com
SUMMARY:2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules
DESCRIPTION:The 2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules will be held from March 25–27\, 2026\, in a hybrid format with options to attend in Tucson\, Arizona\, or virtually. \nOrganized by the Society for Immunotherapy of Cancer (SITC)\, the program will bring together experts in cell therapy\, drug development\, and immuno-oncology to focus on the timely topic of combining next-generation immuno-oncology agents with cellular therapies to treat cancer. \nThe organizing com \nmittee includes Kristen Hege\, MD\, Gordon Moody\, MS\, Daniel Powell\, Jr.\, PhD\, and Evan Weber\, PhD\, and registration for the event opens on August 18\, 2025. \nRegister. \nAbstract Submission.
URL:https://oncodaily.com/event/sitc-spring-scientific-421396
LOCATION:El Conquistador Tucson\, A Hilton Resort\, 10000 N Oracle Rd\, Tucson\, AZ\, 85704\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/1752526849650.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260328
DTSTAMP:20260406T064327
CREATED:20260131T000012Z
LAST-MODIFIED:20260131T000017Z
UID:10000647-1774396800-1774655999@oncodaily.com
SUMMARY:15th European Breast Cancer Conference (EBCC-15)
DESCRIPTION:The 15th European Breast Cancer Conference (EBCC-15) is scheduled to take place from March 25–27\, 2026\, in Barcelona\, Spain. As a premier international multidisciplinary platform established in 1998\, the conference brings together a diverse range of stakeholders – including clinicians\, researchers\, and patient advocates – to discuss critical challenges and the latest advancements in breast cancer care. \nChaired by I. Rubio\, with co-chairs S. Mastora and J. Cortez\, the event focuses on translating new scientific concepts into daily clinical practice. The program is a collaborative effort between the EORTC Breast Cancer Group\, EUSOMA\, and Europa Donna\, offering participants extensive opportunities for networking\, education\, and innovation aimed at improving outcomes for breast cancer patients worldwide. \nRegister.
URL:https://oncodaily.com/event/breast-cancer-conference-449683
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/EBCC15.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Copenhagen:20260325T080000
DTEND;TZID=Europe/Copenhagen:20260328T170000
DTSTAMP:20260406T064327
CREATED:20250712T062245Z
LAST-MODIFIED:20250712T062307Z
UID:10000211-1774425600-1774717200@oncodaily.com
SUMMARY:The European Lung Cancer Congress (ELCC 2026)
DESCRIPTION:The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen\, Denmark\, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science\, sharing education\, and enhancing lung cancer care practices globally. \nWith a comprehensive programme designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians\, interventional radiologists\, and pathologists\, ELCC 2026 offers valuable learning and networking opportunities. Participants are invited to engage in interactive sessions and connect with lung cancer specialists from around the world.
URL:https://oncodaily.com/event/elcc-2026-327158
LOCATION:Bella Center\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7077.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260326
DTEND;VALUE=DATE:20260327
DTSTAMP:20260406T064327
CREATED:20260302T095702Z
LAST-MODIFIED:20260302T100629Z
UID:10000676-1774483200-1774569599@oncodaily.com
SUMMARY:NCCN 2026 Nursing Program: Advancing Oncology Nursing
DESCRIPTION:The NCCN 2026 Nursing Program: Advancing Oncology Nursing is a specialized pre-conference event held on Thursday\, March 26\, 2026\, at the Caribe Royale Orlando in Florida\, with virtual attendance options available.  \nThis program is designed for oncology nurses to engage in case-based learning and expert-led discussions centered on clinical care\, patient communication\, and evidence-based strategies. The 2026 agenda features critical topics including accurate antineoplastic drug administration\, managing gastric and esophageal cancers\, and guiding patients through radiation for head and neck cancers. Participants will also explore complex psychosocial and systemic issues\, such as the impact of extended recovery units on patient outcomes and conducting social determinants of health assessments using the NCCN Distress Thermometer. \nRegister now.
URL:https://oncodaily.com/event/nccn-2026-463283
LOCATION:Caribe Royale Orlando\, 8101 World Center Dr\, Orlando\, Florida\, Orlando\, 32821\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/8622-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260326
DTEND;VALUE=DATE:20260327
DTSTAMP:20260406T064327
CREATED:20260302T100148Z
LAST-MODIFIED:20260302T100148Z
UID:10000677-1774483200-1774569599@oncodaily.com
SUMMARY:NCCN 2026 Oncology Fellows Program: New Horizons in Quality Cancer Care
DESCRIPTION:The NCCN 2026 Oncology Fellows Program: New Horizons in Quality Cancer Care™ is an in-person event held on Thursday\, March 26\, 2026\, at the Caribe Royale Orlando in Florida. \nThis program is specifically designed to meet the educational needs of second- and third-year medical\, surgical\, and radiation oncology fellows. The curriculum focuses on the practical application of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and provides a “behind-the-scenes” look at the evidence-based consensus process used to develop them. Key highlights include sessions on navigating the oncology workforce\, such as contract negotiations and CV building\, alongside clinical updates on cellular therapies and strategies for managing end-of-life care and difficult patient conversations. \nRegister now.
URL:https://oncodaily.com/event/nccn-2026-463287
LOCATION:Caribe Royale Orlando\, 8101 World Center Dr\, Orlando\, Florida\, Orlando\, 32821\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-02T140014.366.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260326
DTEND;VALUE=DATE:20260329
DTSTAMP:20260406T064327
CREATED:20251203T224008Z
LAST-MODIFIED:20251203T224023Z
UID:10000437-1774483200-1774742399@oncodaily.com
SUMMARY:Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions
DESCRIPTION:The ESTRO course on Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions will take place in Rome\, Italy\, from March 26–28\, 2026. \n`Directed by Maximilian Niyazi\, this course is designed to allow radiation oncologists\, medical physicists\, radiation therapists\, and other specialists to deepen their expertise and master advanced SRS/SRT techniques specifically for treating complex cases like brain metastases and skull base lesions\, with an emphasis on practical\, real-world clinical guidance. The early registration deadline for the course is January 7\, 2026.
URL:https://oncodaily.com/event/stereotactic-radiotherapy-421174
LOCATION:Ospedale Isola Tiberina – Gemelli Isola\, Via di Ponte Quattro Capi\, 39\, Rome\, Rome Metropolitan City\, 00186\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Image-9-3.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260326
DTEND;VALUE=DATE:20260329
DTSTAMP:20260406T064327
CREATED:20260223T113220Z
LAST-MODIFIED:20260224T114023Z
UID:10000443-1774483200-1774742399@oncodaily.com
SUMMARY:2026 Japanese Society of Medical Oncology Annual Meeting
DESCRIPTION:The 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2026) will take place from March 26–28\, 2026\, at PACIFICO Yokohama North and Exhibition Hall D in Yokohama\, Japan. \nCentered on the theme “Medical Oncologists for Cancer Patients\,” this year’s meeting marks the 20th anniversary of JSMO’s board certification program and offers a timely opportunity to reflect on the evolving role of medical oncologists in cancer care\, research\, and multidisciplinary practice. JSMO2026 will highlight cutting-edge evidence\, Asian-led oncology advances\, and future directions in education\, collaboration\, and patient-centered cancer care. \nRegister.
URL:https://oncodaily.com/event/japanese-society-of-medical-oncology-421272
LOCATION:PACIFICO Yokohama\, 1 Chome-1-1 Minatomirai\, Nishi Ward\, Yokohama\, Kanagawa\, 220-0012\, Japan
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Annotation-2025-12-04-152603_16x9-Picsart-AiImageEnhancer.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260326T100000
DTEND;TZID=America/Halifax:20260326T100000
DTSTAMP:20260406T064327
CREATED:20260212T125711Z
LAST-MODIFIED:20260212T130000Z
UID:10000652-1774519200-1774519200@oncodaily.com
SUMMARY:Restoring Trust in Science: Storytelling\, AI\, and Integrity in Scholarly Publishing
DESCRIPTION:On March 26\, 2026\, at 10:00 am ET\, ISMPP U will host “Restoring Trust in Science: Storytelling\, AI\, and Integrity in Scholarly Publishing\,” a timely webinar addressing one of the most pressing challenges in research communication today. \nJointly presented by the Council of Science Editors (CSE) and the International Society for Medical Publication Professionals (ISMPP)\, the session will explore how storytelling can rebuild public confidence\, the evolving role of AI in peer review\, and how the scientific community can confront publishing malfeasance. Designed for editors\, researchers\, and medical communications professionals\, the webinar offers practical strategies to strengthen credibility and trust across the publication ecosystem and qualifies for 1.0 CMPP credit. \nRegister now.
URL:https://oncodaily.com/event/science-454879
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-12T165707.523.webp
ORGANIZER;CN="International Society for Medical Publication Professionals":MAILTO:ismpp@ismpp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260330
DTSTAMP:20260406T064327
CREATED:20260227T110356Z
LAST-MODIFIED:20260227T110414Z
UID:10000675-1774569600-1774828799@oncodaily.com
SUMMARY:NCCN Annual Conference 2026
DESCRIPTION:The NCCN Annual Conference 2026 will be held from March 27–29\, 2026\, at the Caribe Royale Orlando in Florida\, with virtual attendance options also available. \nThis conference brings together oncology leaders to share cutting-edge cancer research and provide actionable strategies to improve patient outcomes through evidence-based\, expert consensus-driven NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Key highlights include the debut of a new\, in-person only Operational Excellence in Cancer Care Program focused on increasing patient access\, integrating emerging technology\, and optimizing the workforce. The agenda also features plenary sessions on supporting younger adults across the care continuum\, navigating global cancer care strategies\, and managing immune checkpoint inhibitor toxicities. \nRegister now.
URL:https://oncodaily.com/event/nccn-462064
LOCATION:Caribe Royale Orlando\, 8101 World Center Dr\, Orlando\, Florida\, Orlando\, 32821\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-27T150326.761.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
DTSTAMP:20260406T064327
CREATED:20260315T140249Z
LAST-MODIFIED:20260315T140249Z
UID:10000697-1774569600-1774655999@oncodaily.com
SUMMARY:NECTA Drug Development Meeting 2026
DESCRIPTION:The NECTA Drug Development Meeting 2026 will be held on Friday\, 27 March 2026\, at the Garvan Institute of Medical Research in Sydney. \nThis specialized forum focuses on critical shifts in early-phase oncology\, including the reformation of dose optimization and the challenges of agnostic precision oncology for unknown targets. The agenda also highlights novel clinical trial insights from the Asian market and a dedicated focus on the wellbeing of clinical coordinators and clinicians. Attendance is available both in-person at the Darlinghurst auditorium and online\, with the meeting offering free registration for academic and clinical professionals. \nRegister.
URL:https://oncodaily.com/event/necta-469595
LOCATION:The Garvan Institute of Medical Research\, 384 Victoria St (Entrance via Burton Street)\, Darlinghurst\, Sydney\, NSW\, 2010\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-15T180315.823.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260329
DTSTAMP:20260406T064327
CREATED:20251214T211246Z
LAST-MODIFIED:20251214T211310Z
UID:10000495-1774569600-1774742399@oncodaily.com
SUMMARY:Summit on Cancer Health Disparities (SCHD26)
DESCRIPTION:The Summit on Cancer Health Disparities (SCHD26) is a two-day conference organized by Binaytara\, scheduled for March 27–28\, 2026\, at the Hyatt Regency Bellevue in Bellevue\, Washington\, United States. \nThis summit is dedicated to addressing the critical issue of cancer health disparities. Attendees can earn up to 12.75 credits\, and the conference is designed to bring together healthcare professionals to learn about and collaborate on strategies to improve equity and access in cancer care. \nRegister.
URL:https://oncodaily.com/event/summit-on-cancer-health-disparities-428421
LOCATION:Hyatt Regency Bellevue on Seattle’s Eastside\, 900 Bellevue Way NE\, Bellevue\, WA\, 98004\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/OncoDaily-2025-10-02-220157.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260329
DTSTAMP:20260406T064327
CREATED:20251221T215346Z
LAST-MODIFIED:20251221T215356Z
UID:10000516-1774569600-1774742399@oncodaily.com
SUMMARY:13th Belgian Multidisciplinary Meeting on Urological Cancers (BMUC 2026)
DESCRIPTION:The 13th Belgian Multidisciplinary meeting on Urological Cancers (BMUC 2026) is a specialized oncology congress scheduled for Friday\, March 27\, and Saturday\, March 28\, 2026. \nOrganized by the Belgian Multidisciplinary Urology Group\, the meeting serves as a key platform for urologists\, medical oncologists\, and radiation oncologists to discuss the latest multidisciplinary management strategies for urological malignancies. The event will be hosted at the Holiday Inn Brussels Airport
URL:https://oncodaily.com/event/belgian-multidisciplinary-meeting-432399
LOCATION:Holiday Inn Brussels Airport\, Holidaystraat 7\, Diegem\, Flemish Brabant\, 1831\, Belgium
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BMUC.webp
ORGANIZER;CN="BMUC":MAILTO:info@bmuc.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260329
DTSTAMP:20260406T064327
CREATED:20251228T200812Z
LAST-MODIFIED:20251228T200821Z
UID:10000540-1774569600-1774742399@oncodaily.com
SUMMARY:ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing
DESCRIPTION:The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28\, 2026\, in Beijing\, China. \nCo-chaired by Giuseppe Curigliano and Binghe Xu\, this 1.5-day course is specifically designed for experienced oncologists and oncology specialists to deepen their understanding of CDK4/6 inhibition in both early and metastatic HR+/HER2- breast cancer settings. The course is accredited with 11 ESMO-MORA category 1 points\, serving as a vital platform for clinicians in the Asia-Pacific region to integrate the latest evidence into precision breast cancer management. \nApplication.
URL:https://oncodaily.com/event/esmo-advanced-course-435266
LOCATION:Beijing\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-3.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260329
DTSTAMP:20260406T064327
CREATED:20260106T215127Z
LAST-MODIFIED:20260106T215135Z
UID:10000561-1774569600-1774742399@oncodaily.com
SUMMARY:Emirates Digestive Diseases Week 2026
DESCRIPTION:The Emirates Digestive Diseases Week (EDDW) 2026 is the Middle East’s premier educational platform for gastroenterology and hepatology. Scheduled for March 27–28\, 2026\, in Dubai\, UAE\, the 10th-anniversary edition will focus on “Advancing Digestive Health Through Innovation and Collaboration.” \nThe scientific program features sessions endorsed by major international bodies\, including ESGE\, ECCO\, and the BSG\, with a technical curriculum that includes live demonstrations of advanced endoscopic procedures such as EMR\, ESD\, POEM\, and EUS\, as well as dedicated tracks for Inflammatory Bowel Disease (IBD) and GI Nursing. \nRegister.
URL:https://oncodaily.com/event/emirates-digestive-diseases-week-437628
LOCATION:Le Méridien Dubai Hotel & Conference Centre\, Airport Rd - Al Garhoud\, Dubai\, United Arab Emirates
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/EDDW.webp
ORGANIZER;CN="Emirates Digestive Diseases Week (EDDW)":MAILTO:info@eddw.ae
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260331
DTSTAMP:20260406T064327
CREATED:20260105T214356Z
LAST-MODIFIED:20260105T214402Z
UID:10000558-1774569600-1774915199@oncodaily.com
SUMMARY:EASL Congress 2026
DESCRIPTION:The EASL Congress 2026\, organized by the European Association for the Study of the Liver\, is Europe’s largest event dedicated to hepatology. It is scheduled to take place from May 27–30\, 2026\, in Barcelona\, Spain\, with a virtual attendance option available. \nThe congress covers the full spectrum of liver health\, including significant technical focus on Liver Cancer (Hepatocellular Carcinoma)\, cirrhosis\, and liver transplantation. The scientific program includes a Postgraduate Course\, a Basic Science Seminar\, and specialized sessions on the latest diagnostic and therapeutic breakthroughs. The event is expected to host over 8\,000 professionals and feature more than 2\,000 abstract presentations. \nRegister.
URL:https://oncodaily.com/event/easl-437194
LOCATION:Fira de Barcelona\, Av. Joan Carles I\, 64\, L’hospitalet de Llobregat\, Barcelona\, Catalonia\, 08908\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/EASL-2026.webp
ORGANIZER;CN="European Association for the Study of the Liver (EASL)":MAILTO:easloffice@easloffice.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260327T090000
DTEND;TZID=America/Halifax:20260327T100000
DTSTAMP:20260406T064327
CREATED:20260306T055023Z
LAST-MODIFIED:20260306T055059Z
UID:10000687-1774602000-1774605600@oncodaily.com
SUMMARY:Reliable leukemia subtyping with machine learning and conformal prediction? - Resonance
DESCRIPTION:The ALRCaN Global webinar\, “Reliable leukemia subtyping with machine learning and conformal prediction?” is set for Friday\, March 27\, 2026\, from 09:00 AM to 10:00 AM ET.  \nLed by Mariya Lysenkova Wiklander\, this session examines improving leukemia classification through advanced computational methods. Organized by ALRCaN Global and Resonance Health\, and supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer\, this forum allows experts to explore integrating machine learning into clinical diagnostics for better hemato-oncology outcomes.
URL:https://oncodaily.com/event/leukemia-465270
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Gemini_Generated_Image_wte8jpwte8jpwte8.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260401
DTEND;VALUE=DATE:20260402
DTSTAMP:20260406T064327
CREATED:20251228T201317Z
LAST-MODIFIED:20251228T201327Z
UID:10000541-1775001600-1775087999@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026 webinar\, scheduled for April 1\, 2026\, focuses on the integration of precision diagnostics and innovative therapies in the management of Renal Cell Carcinoma (RCC). \nChaired by Viktor Gruenwald\, the program addresses the clinical challenges of treatment sequencing and patient selection in a rapidly evolving therapeutic landscape. Key sessions cover molecular tailoring for treatment stratification\, the emergence of molecular imaging as a diagnostic and therapeutic tool\, and evidence-based strategies for second-line management of metastatic RCC. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-435270
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260403T090000
DTEND;TZID=America/Halifax:20260403T100000
DTSTAMP:20260406T064327
CREATED:20260317T120117Z
LAST-MODIFIED:20260317T120117Z
UID:10000699-1775206800-1775210400@oncodaily.com
SUMMARY:Newly Diagnosed AML: 2026 Treatment Algorithms - Resonance
DESCRIPTION:The ALRCaN Global webinar\, “Newly diagnosed AML: 2026 Treatment algorithms” is set for Friday\, April 03\, 2026\, from 09:00 AM to 10:00 AM ET. \nLed by Dr. Naseema Gangat\, this session examines current treatment strategies and algorithms for acute myeloid leukemia. Organized by ALRCaN Global and Resonance Health\, and supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer\, this forum allows experts to enjoy lively discussion of leukemia and supportive care topics. This activity has been approved for AMA PRA Category 1 Credit™.
URL:https://oncodaily.com/event/aml-470425
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Naseema-Gangat-1-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260407T100000
DTEND;TZID=America/Halifax:20260407T140000
DTSTAMP:20260406T064327
CREATED:20251210T223635Z
LAST-MODIFIED:20251210T223659Z
UID:10000472-1775556000-1775570400@oncodaily.com
SUMMARY:Application of External Control Arms in Oncology Drug Development
DESCRIPTION:The public meeting\, “Application of External Control Arms in Oncology Drug Development\,” hosted by Friends of Cancer Research\, is scheduled for Tuesday\, April 7\, 2026\, from 10:00 AM to 2:00 PM ET\, at The Ritz-Carlton in Washington\, DC\, with a virtual streaming option available. \nThe purpose of the meeting is to explore opportunities for advancing the use of External Control Arms (ECAs)\, which are constructed from existing data sources like prior clinical trials or real-world data\, to enhance oncology drug development\, particularly when traditional randomized trials are impractical. \nRegister.
URL:https://oncodaily.com/event/external-control-arms-425839
LOCATION:The Ritz-Carlton\, Washington\, D.C\, 1150 22nd St NW\, Washington\, DC\, 20037\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ODD.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260408
DTEND;VALUE=DATE:20260411
DTSTAMP:20260406T064327
CREATED:20251105T202029Z
LAST-MODIFIED:20251203T225444Z
UID:10000325-1775606400-1775865599@oncodaily.com
SUMMARY:SIOG Research Masterclass 2026
DESCRIPTION:The SIOG 2026 Research Masterclass is an intensive\, three-day course organized by the International Society of Geriatric Oncology (SIOG)\, running from April 8 to April 10\, 2026. The event will be held at the Hilton St. Petersburg Bayfront in Tampa\, Florida\, U.S.. \nIts core focus is to equip early-career clinical investigators and other professionals with essential attributes for designing clinical studies that are centered on the currently underrepresented older adult cancer population. The objective is to provide world-class training to address hidden inclusion criteria that often exclude older cancer patients from randomized control studies.
URL:https://oncodaily.com/event/siog-403721
LOCATION:Hilton St. Petersburg Bayfront\, 333 1st St SE\, Saint Petersburg\, FL\, 33701-4342\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/12/SIOG.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260408
DTEND;VALUE=DATE:20260412
DTSTAMP:20260406T064327
CREATED:20260315T141001Z
LAST-MODIFIED:20260315T141001Z
UID:10000698-1775606400-1775951999@oncodaily.com
SUMMARY:International Conference on Assisted Dying and Other End-of-Life Care (ICEL5)
DESCRIPTION:The International Conference on Assisted Dying and Other End-of-Life Care (ICEL5)\, hosted by the Australian Centre for Health Law Research\, will take place from 8–11 April 2026 at the Queensland University of Technology (QUT) in Brisbane. \nThis four-day interdisciplinary symposium serves as a global platform for academics\, legal experts\, and healthcare practitioners to analyze the complex intersection of ethics\, clinical practice\, and policy within end-of-life care. Led by a scientific committee of international experts from Australia\, Belgium\, Canada\, the Netherlands\, and the USA\, the program focuses on sharing empirical research and multi-jurisdictional perspectives to address the evolving legal and clinical landscapes of assisted dying. \nRegister.
URL:https://oncodaily.com/event/icel5-469609
LOCATION:Queensland University of Technology\, QUT Gardens Point Campus\, 2 George St\, Brisbane\, QLD\, 4000\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Annotation-2026-03-15-180954-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260409
DTEND;VALUE=DATE:20260412
DTSTAMP:20260406T064327
CREATED:20251022T220528Z
LAST-MODIFIED:20251022T220607Z
UID:10000285-1775692800-1775951999@oncodaily.com
SUMMARY:Texas Lung Cancer Conference 2026
DESCRIPTION:The 2026 Texas Lung Cancer Conference (TLC 2026) is scheduled to take place from April 9 to 11\, 2026\, at ACL Live at The Moody Theater in Austin\, Texas. This CE-accredited\, in-person event will convene over 100 leading national experts\, rising faculty\, and community oncologists for two days of case-driven education focused on the latest advancements in lung cancer diagnosis\, treatment\, and patient-centered care.\nthetlcconference.com \nThe conference is co-chaired by Dr. Tina Cascone of MD Anderson Cancer Center and Dr. Stephen Liu of Georgetown University. Attendees can expect a dynamic program featuring panel discussions\, interactive sessions\, and networking opportunities. \nThe event will also host a scientific poster competition\, with abstract submissions due by November 28\, 2025\, and winners notified by December 12\, 2025. \nHotel accommodations and additional conference activities will be held at The W Austin\, located adjacent to ACL Live by a connecting walkway. Attendees are encouraged to reserve their rooms early to take advantage of the TLC special group rate. \nYou can find more posts on the Texas Lung Cancer Conference on OncoDaily.
URL:https://oncodaily.com/event/texas-lung-cancer-conference-396353
LOCATION:ACL Live at the Moody Theater\, 310 W 2nd St\, Austin\, Austin\, Texas\, 78701
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/GyVbdsOXMAAjSn1.jpg
ORGANIZER;CN="IDEOlogy Health":MAILTO:conferences@IDEOlogyHealth.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260410
DTEND;VALUE=DATE:20260412
DTSTAMP:20260406T064327
CREATED:20250223T115328Z
LAST-MODIFIED:20260224T114134Z
UID:10000444-1775779200-1775951999@oncodaily.com
SUMMARY:APPOS Tampa 2026: Advanced Practice Providers Oncology Summit
DESCRIPTION:The APPOS Tampa 2026: Advanced Practice Providers Oncology Summit will be held April 10–11\, 2026\, in Tampa\, Florida\, USA. \nThis two-day conference is designed for advanced practice providers—including nurse practitioners\, physician assistants\, pharmacists\, and oncology nurses—and focuses on evidence-based strategies for the multidisciplinary treatment and management of oncology patients. Attendees can earn continuing education (CE) credits while learning practical approaches to improve patient care and interprofessional collaboration. \nRegister.
URL:https://oncodaily.com/event/appos-tampa-421301
LOCATION:The Westin Tampa Waterside\, 725 South Harbour Island Boulevard\, Tampa\, FL\, 33602\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-2025-12-04T155305865-Picsart-AiImageEnhancer.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
END:VCALENDAR